Pay in 4 interest-free payments of $30.50 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
In hemophilia A and von Willebrand disease
a derivative of Raloxifene
EMI1 (1 nM-100μM) strongly inhibits the viability and increase the caspase 3/7 activity of PC9 EGFR ex19del/T790M/C797S triple-mutant cells than noncancerous human bronchial epithelial (HBE) cells
When administered systemically to mice
(-)-Epinephrine
Gatifloxacin sesquihydrate opropane-F In hemophilia A and vonGatifloxacin sesquihydrate (AM 1155; BMS 206584; PD135432) is a potent fluoroquinolone antibiotic with broad spectrum antibacterial activity. Gatifloxacin sesquihydrate inhibits bacterial type II topoisomerases (IC50=13. 8 g ml for S. aureus topoisomerase IV) and E. coli DNA gyrase (IC50 = 0. 109 g ml). Gatifloxacin sesquihydrate can be used to treat bacterial conjunctivitis in vivo. Product information CAS Number: 180200 66 2 Molecular Weight: 402.
US$ 154.50
US$ 17.00
US$ 101.50
US$ 88.00
US$ 174.50